The S&P 500 struggled for direction on Tuesday as the risks of reopening the economy too soon overshadowed hopes of a jump-start to a battered global economy, following an easing of virus-led business shutdowns.
(Bloomberg) — JPMorgan Chase & Co.’s asset-management arm has launched a new fund to take advantage of dislocations in the public and private real estate credit markets, according to a person familiar with the matter.JPMorgan Asset Management is looking to raise $2 billion to $3 billion from institutional investors for the Real Estate Credit Opportunity Fund, according to the person, who asked not to be identified because the information is private.The vehicle will target 10% to 15% net returns investing in bonds and pools of loans tied to commercial real estate, according to documents viewed by Bloomberg. The fund will …read more […]
(Bloomberg) — Billionaire Anil Agarwal plans to take Indian commodities giant Vedanta Ltd. private as the tycoon continues to simplify his investments.The businessman is proposing a price of 87.5 rupees ($1.16) per share to buy the 49.9% he doesn’t own of the company from minority investors, a 9.9% premium over Monday’s closing price, his holding company said in a statement Tuesday. The announcement confirmed an earlier story by Bloomberg News.Vedanta shares have fallen more than 40% this year, giving the company a market value of about $4.4 billion. Taking the company private is the “next logical step” in its simplification …read more […]
Uber Technologies Inc has made an offer to buy online food delivery company GrubHub Inc , Bloomberg News reported on Tuesday.
Lawmakers pressed U.S. regulators on Tuesday on their efforts to help struggling consumers, oversight of massive federal bailout packages and regulatory easing as they appeared before Congress for the first time since the novel coronavirus outbreak.
Uber reportedly approached Grubhub with a buyout offer, according to Bloomberg. Tom White, Senior Vice President & Senior Research Analyst at D.A. Davidson joins Yahoo Finance’s On The Move to weigh in. …read more […]
Moderna Inc. (MRNA) announced on Tuesday that its experimental coronavirus vaccine has been granted fast track status by the U.S. Food and Drug Administration (FDA).The fast track status designation is awarded to speed up the regulatory review of its novel coronavirus vaccine candidate (mRNA-1273).Last week, the FDA completed its review of Moderna’s Investigational New Drug (IND) application for mRNA-1273 allowing it to proceed to a Phase 2 study, which is expected to begin shortly. The clinical stage biotech company said it is finalizing the protocol for a Phase 3 study, expected to begin in early summer of 2020.“Fast Track designation …read more […]
Yahoo Finance’s Brian Sozzi and Rick Newman discuss Elon Musk’s latest moves amid the coronavirus outbreak, and President Trump’s reaction. …read more […]
Uber reportedly approached takeout food-delivery service Grubhub with a takeover offer, according to Bloomberg. Yahoo Finance’s Jared Blikre shares the details. …read more […]
Luckin Coffee Inc has fired its chief executive and chief operating officers following an internal probe on fabrication of annual sales numbers, the Chinese coffee chain said https://bit.ly/3cD4jLC in a filing on Tuesday.
U.S. consumer prices dropped by the most since the Great Recession in April, weighed down by a plunge in demand for gasoline and services including airline travel as Americans stayed home during the coronavirus crisis.
Yahoo Finance’s Brian Sozzi and Heidi Chung break down the market action for Apple. …read more […]
The S&P 500 slipped in choppy trading on Tuesday as the risks of reopening the economy too soon overshadowed hopes of a jump-start to a battered global economy, following an easing of virus-led business shutdowns.
Novavax stock is one of the biggest movers in the market right now. The Maryland-based vaccine company announced a massive investment that may be a saving grace in the fight against the coronavirus.
Why is Novavax Stock on the Rise?
Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage vaccine company with facilities in Maryland and Sweden. Like most biotech companies, it has joined in the fight against COVID-19.
However, it’s quickly making strides towards a vaccination candidate that has caught the eyes of investors. The Coalition for Epidemic Preparedness Innovations (CEPI) will invest up to an additional $384 million to advance the potential vaccine’s …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
